Two Penguins Investment
Preparing your financial briefing…
Financial Intelligence
Recent perspective
Recent financial reporting selected by recency, stored importance, and source diversity.
Live chronology
Page 505 · Newest reporting first
Nasdaq Marketsmarketsinvestment opinion
Berkshire Hathaway took an action for the first time in 15 quarters, according to the article. The piece suggests historical patterns may offer clues about what follows, though recent evidence may point to a different outcome.
CoinDeskmarketsinvestment opinion
An analysis of six years of bitcoin price data suggests the U.S. nonfarm payrolls report has not been a major price mover. The finding challenges assumptions about the report's significance for crypto markets.
Nasdaq Marketsmarketsinvestment opinion
A global REIT is compared with the Schwab U.S. REIT ETF on yield. The article questions whether the higher-yielding global fund is a better buy for real estate investors.
Nasdaq Marketsmarketsinvestment opinion
The article argues that most AI stocks already trade at elevated valuations. It highlights a different AI stock that may have the most upside potential.
CNBC Top Newsmacroeconomic data
A new Altrata report shows the global billionaire count reached a record 3,795 people last year. Total billionaire wealth hit $15.1 trillion, with the largest gains concentrated among the wealthiest individuals.
Nasdaq Marketsmarketsinvestment opinion
The article calculates how many PepsiCo shares an investor would need to generate $25,000 in annual dividend income. It highlights the substantial capital required for that level of dividend payout.
Nasdaq Marketsmarketsinvestment opinion
Wall Street analysts remain bullish on NuScale Power despite the stock's struggles this year. The article outlines three reasons supporting their positive outlook.
Nasdaq Marketsmarketsinvestment opinion
The article compares NuScale Power and Oklo as leading small modular reactor stocks. It evaluates which nuclear company may be the better buy at present.
Nasdaq Marketscompaniescorporate event
Immuron signed an exclusive U.S. distribution deal with Sweden's Calmino group AB for its digestive health product PROIBS. The launch follows the product's rollout in Australia, and pre-market shares rose.
CNBC Top Newsregulationregulatory action
THC-infused drinks are growing rapidly as an alcohol alternative. A potential federal crackdown is creating uncertainty for makers, distributors, and consumers.